以上来源于: WordNet
Had the DSMB halted IMPROVE-IT due to safety reasons, it would have been a great shock.
FORBES: Cholesterol Drug Heart Study Continues, But Will Merck's Vytorin Really IMPROVE-IT?
As Merck announced, the DSMB gave the green light for the study to continue for another year.
Like all major outcome studies, the IMPROVE-IT trial is being monitored by an independent data safety monitoring board (DSMB).
应用推荐
模块上移
模块下移
不移动